History

COMPANY / History

History

2020s

2020
Jan

Exclusive sales agreement contract signed with Mundipharma for CartiLife®.

2010s

2019
Apr

Autologous Chondrocyte Cell Theraphy CartiLife registered for sale.

Apr

Human tissue model registered as OECD TG.

Apr

CartiLife core technology (pellet-type cartilage) patent registered in the EU.

Jan

BSP-11 core technology patented.

2018
Nov

CartiLife core technology (pellet-type cartilage) patent registered in Japan.

Aug

Company listed on the KOSDAQ Market.

May

CartiLife core technology (pellet-type cartilage) patent registered in USA.

Apr

Cornea irritation test using MCTT HCETM registered on the OECD WNT.

Jan

Stim Mobil Gel core technology patent registered.

2017
Dec

CartiLife core technology (pellet-type cartilage) patent registered

Nov

Special award received in Lush Prize Animal Substitution Test Field.

Nov

CartiLife approved as 'New Excellent Technology' (NET) by the Korea Health Industry Development Institute

Oct

Company registered as a 'K-BrainPower' company by the Korean Ministry of Trade, Industry and Energy.

Jul

Costal cartilage core technology patent registered in USA.

May

Costal cartilage core technology patent registered in EU.

2016
Feb

Registered on the Patent List for Medicine at the Korea Food & Drugs Administration

Jan

Changed Name of Company to Biosolution Co., Ltd.

2015

Allogeneic keratinocyte therapy product KeraHeal-Allo approved for sale.

Accreditation of Excellent Academic Contribution for the Implementation of Bioethics (Korean Society for Alternative to Animal Experiments)

2014

Manufacturing plant (GMP) expansion transfer.

Costal cartilage core technology patented in China.

2013

KeraHeal approval after re-evaluation.

2012

Changed company name to MCTT BIO Co., Ltd.

2000s

2010

Launched STeM水, Extract from Stem Cell Culture Media

2009

KeraHeal Approved for Coverage under the Occupational Health and Safety Insurance

2006

Received License for KeraHeal, an Autologous Keratinocyte Therapy Product

2000

Established Company and Received Approval for the R&D Center